Medpace Holdings Inc (OQ:MEDP)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEC
Company Contact
Address: 5375 Medpace Way
CINCINNATI OH 45227-1543
Tel: N/A
IR: See website
Key People
August J. Troendle
Chairman of the Board, President, Chief Executive Officer
Jesse J. Geiger
Chief Financial Officer, Chief Operating Officer - Laboratory Operations
Susan E. Burwig
Executive Vice President - Operations
Stephen P. Ewald
General Counsel, Corporate Secretary
Business Overview
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Financial Overview
For the six months ended 30 June 2020, Medpace Holdings Inc revenues increased 5% to $435.9M. Net income applicable to common stockholders increased 14% to $52.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 55% to $4M (expense), Interest expense, net decrease of 100% to $5K (expense), Miscellaneous (expense) income.
Employees: 3,400 as of Jun 30, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $4,160M as of Jun 30, 2020
Annual revenue (TTM): $882.00M as of Jun 30, 2020
EBITDA (TTM): $151.22M as of Jun 30, 2020
Net annual income (TTM): $106.56M as of Jun 30, 2020
Free cash flow (TTM): $187.84M as of Jun 30, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 35,408,120 as of Jun 30, 2020
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.